Search Results - "antiviral"

P28 Queensland injectors health network (QuIHN) treatment management program (TMP): hepatitis C virus (HCV) direct acting antivirals (DAA) full access for people who inject drugs by R. Kavanagh, T. Nuckey, S. Dodd, G. Keogh, A. Kvassay, N. Alexander

Connect to this object online.

A meta-analysis of the antiviral activity of the HBV-specific immunotherapeutic TG1050 confirms its value over a wide range of HBsAg levels in a persistent HBV pre-clinical model by Roland Kratzer, Benoît Sansas, Karine Lélu, Alexei Evlachev, Doris Schmitt, Nathalie Silvestre, Geneviève Inchauspé, Perrine Martin

Connect to this object online.

Retraction notice to: "Antiviral treatment could not provide clinical benefit in management of mild COVID-19: A Retrospective Experience from Field hospital" [Journal of Infection and Public Health14/9 (2021) 1206- 1211] by Natsuda Aumpan, Ratha-korn Vilaichone, Sarita Ratana-Amornpin, Surat Teerakapibal, Pisanu Toochinda, Gasinee Witoonchart, Surapon Nitikraipot

Connect to this object online.

Expanding reimbursement of immediate treatment using direct acting antivirals to reduce hepatitis C incidence among HIV positive men who have sex with men in Bangkok, Thailand: A cost effectiveness modelling study by Shreoshee Mukherjee, Donn Colby, Reshmie Ramautarsing, Stephanie Popping, Somchai Sriplienchan, Tanat Chinbunchorn, Nittaya Phanuphak, David van de Vijver

Connect to this object online.

Recent CMV Research

Subjects: “…antiviral defense…”
DOAB: download the publication
DOAB: description of the publication

Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages.... by Israel S. Maia, Aline Marcadenti, Viviane C. Veiga, Tamiris A. Miranda, Samara P.C. Gomes, Mariana B.S. Carollo, Karina L. Negrelli, Jackeline O. Gomes, Lucas Tramujas, Erlon O. Abreu-Silva, Glauco A. Westphal, Ruthy P. Fernandes, Jacques G.A. Horta, Deborah C. Oliveira, Uri A.P. Flato, Ricardo C.R. Paoliello, Camilo Fernandes, Cássio L. Zandonai, Juliana C. Coelho, Waldemar C. Barros, Juliana C. Lemos, Renata S. Bolan, Marcela M. Dutra, Otavio C.E. Gebara, Ana T.A. Lopes, Meton S. Alencar Filho, Jussara A. Arraes, Victor A. Hamamoto, Mauro E. Hernandes, Nicole A. Golin, Tiago M. Santos, Renato H.N. Santos, Lucas P. Damiani, Fernando G. Zampieri, João Gesto, Flávia R. Machado, Régis G. Rosa, Luciano C.P. Azevedo, Alvaro Avezum, Renato D. Lopes, Thiago M.L. Souza, Otávio Berwanger, Alexandre B. Cavalcanti

Connect to this object online.

Biological hepatic markers of inflammation and fibrosis following durable sustained virological response to direct acting antiviral agents in HIV/HCV co-infected patients: preliminary results from the cohort driven by the CoReVIH at the University-Hospital of Clermont-Ferrand, France by Guillaume Laurichesse, Sandrine Casanova, Audrey Mirand, Violaine Corbin, Paule Letertre, Natacha Mrozek, Magali Vidal, Cécile Henquel, Henri Laurichesse, Christine Jacomet

Connect to this object online.

Papel del genotipo y variantes precore/core del virus de la hepatitis B en el curso clínico y el tratamiento Rol of Hepatitis B virus genotype and precore/core variants on antiviral treatment response and clinical outcome by Fabián Mauricio Cortés-Mancera, María Cristina Navas

Connect to this object online.

Recent Progress in Bunyavirus Research by Pierre-Yves Lozach

Subjects: “…Antiviral therapeutics…”
DOAB: download the publication
DOAB: description of the publication

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study by Yin-Qiu Huang, Sheng-Quan Tang, Xiao-Lei Xu, Yan-Ming Zeng, Xiao-Qing He, Yao Li, Vijay Harypursat, Yan-Qiu Lu, Yan Wan, Lu Zhang, Qiang-Zhong Sun, Nan-Nan Sun, Gui-Xue Wang, Zhong-Ping Yang, Yao-Kai Chen, Yao-Kai Chen

Connect to this object online.

Toxin and Immunotoxin Based Therapeutic Approaches

Subjects: “…antiviral agent…”
DOAB: download the publication
DOAB: description of the publication

In Memory of Stefan Kunz

Subjects: “…antiviral drug…”
DOAB: download the publication
DOAB: description of the publication

Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers 2.0

Subjects: “…antiviral drugs…”
DOAB: download the publication
DOAB: description of the publication

Actinobacteria and Myxobacteria Important Resources for Novel Antibiotics

Subjects: “…antivirals…”
DOAB: download the publication
DOAB: description of the publication

New Advances on Zika Virus Research by Martinez-Sobrido, Luis

Subjects: “…antivirals…”
DOAB: download the publication
DOAB: description of the publication

The Role of Toll-Like Receptors (TLR) in Infection and Inflammation

Subjects: “…antiviral…”
DOAB: download the publication
DOAB: description of the publication

Pseudorabies Virus

Subjects: “…antiviral…”
DOAB: download the publication
DOAB: description of the publication

Biological Activities of Ribosome-Inactivating Proteins

Subjects: “…antiviral proteins…”
DOAB: download the publication
DOAB: description of the publication

Biological Activities of Ribosome-Inactivating Proteins

Subjects: “…antiviral proteins…”
DOAB: download the publication
DOAB: description of the publication

Chronic HCV Infection: Clinical Advances and Eradication Perspectives

Subjects: “…direct-acting antivirals…”
DOAB: download the publication
DOAB: description of the publication